Pilot study of lonafarnib, a farnesyl transferase inhibitor, in patients with chronic myeloid leukemia in the chronic or accelerated phase that is resistant or refractory to imatinib therapy

Gautam Borthakur, Hagop Kantarjian, George Daley, Moshe Talpaz, Susan O'Brien, Guillermo Garcia-Manero, Francis Giles, Stefan Faderl, Mary Sugrue, Jorge Cortes*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

62 Scopus citations

Fingerprint

Dive into the research topics of 'Pilot study of lonafarnib, a farnesyl transferase inhibitor, in patients with chronic myeloid leukemia in the chronic or accelerated phase that is resistant or refractory to imatinib therapy'. Together they form a unique fingerprint.

INIS

Pharmacology, Toxicology and Pharmaceutical Science